
According to Benzinga Pro data, during Q1, Seattle Genetics (NASDAQ:SGEN) posted sales of $426.46 million. Earnings were up 21.84%, but Seattle Genetics still reported an overall loss of $136.49 million. In Q4, Seattle Genetics brought in $429.85 million in sales but lost $174.63 million in earnings.